구조모아 (StructureMoa)항암 chemical structure spider web
방문타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | rh IL-15 (5 DAYS) |
Overview Company | National Cancer Institute (NCI) |
Overview Modality | CGT |
Overview Target | Lymphoma |
Overview Indication | Lymphoma; Carcinoma |
Overview Phase | PHASE_1 |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Phototherapy, Morbidity, and Mortality in Very Preterm Newborns.. Phototherapy is widely used in the care of preterm newborns to prevent brain damage resulting from hyperbilirubinemia. However, concerns regarding its safety have been raised. To determine the associations between phototherapy and neonatal mortality or morbidity. This population-based cohort study from the Swedish Neonatal Quality R… |
Clinical Safety signal | Phototherapy, Morbidity, and Mortality in Very Preterm Newborns.. Phototherapy is widely used in the care of preterm newborns to prevent brain damage resulting from hyperbilirubinemia. However, concerns regarding its safety have been raised. To determine the associations between phototherapy and neonatal mortality or morbidity. This population-based cohort study from the Swedish Neonatal Quality R… |
Clinical Selected reported efficacy | ORR 76.7% |
Clinical Reported ORR | 76.7% |
Clinical Result source | ClinicalTrials.gov NCT02980731 |
Clinical Program phase | PHASE_1 |
Clinical Trial ref | NCT02980731 |
타깃 · 모달리티 · 임상 근거 · 비임상 맥락으로 최대 5개 프로그램을 나란히 비교합니다. · 다음 갱신 D-6 · 마지막 9월 2일
현재 선택: 1개 · 임상 갱신 필요 1개
프로그램 상세에서 관심 등록 후 2개 이상 모으면 여기서 한 번에 비교할 수 있습니다.
표가 넓으면 좌우로 스크롤하세요. 핵심 비교 모드에서는 중요 항목만 표시됩니다.
| 항목 | |
|---|---|
Overview Program | rh IL-15 (5 DAYS) |
Overview Company | National Cancer Institute (NCI) |
Overview Modality | CGT |
Overview Target | Lymphoma |
Overview Indication | Lymphoma; Carcinoma |
Overview Phase | PHASE_1 |
Overview Status | ACTIVE |
Overview Content status | Standard Database |
Overview Data Confidence | Data Confidence · Medium |
Overview Development Signal | Development Signal · Watch |
Overview Approval status | Investigational |
Toxicology Major finding | Phototherapy, Morbidity, and Mortality in Very Preterm Newborns.. Phototherapy is widely used in the care of preterm newborns to prevent brain damage resulting from hyperbilirubinemia. However, concerns regarding its safety have been raised. To determine the associations between phototherapy and neonatal mortality or morbidity. This population-based cohort study from the Swedish Neonatal Quality R… |
Clinical Safety signal | Phototherapy, Morbidity, and Mortality in Very Preterm Newborns.. Phototherapy is widely used in the care of preterm newborns to prevent brain damage resulting from hyperbilirubinemia. However, concerns regarding its safety have been raised. To determine the associations between phototherapy and neonatal mortality or morbidity. This population-based cohort study from the Swedish Neonatal Quality R… |
Clinical Selected reported efficacy | ORR 76.7% |
Clinical Reported ORR | 76.7% |
Clinical Result source | ClinicalTrials.gov NCT02980731 |
Clinical Program phase | PHASE_1 |
Clinical Trial ref | NCT02980731 |
추천 비교
추천 비교